OCTAPLEX
OCTAPLEX
Approved
DIN Number
02434970
Drug Class
Human
Market Date
Aug 11, 2015
Company
HC
octapharma pharmazeutika produktionsges m b h
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02434970
AIG Number0652205005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD01 COAGULATION FACTOR IX, II, VII AND X IN COMB
Product Specifications
Dosage FormPowder For Solution
,
Kit
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (6)
COAGULATION FACTOR II (HUMAN)Active
Strength: 1520 UNIT / VIAL
Monograph: COAGULATION FACTOR II (HUMAN)
COAGULATION FACTOR IX (HUMAN)Active
Strength: 1000 UNIT / VIAL
Monograph: COAGULATION FACTOR IX (HUMAN)
COAGULATION FACTOR VII (HUMAN)Active
Strength: 960 UNIT / VIAL
Monograph: COAGULATION FACTOR VII (HUMAN)
COAGULATION FACTOR X (HUMAN)Active
Strength: 1200 UNIT / VIAL
Monograph: COAGULATION FACTOR X (HUMAN)
PROTEIN CActive
Strength: 1240 UNIT / VIAL
Monograph: PROTEIN C
PROTEIN SActive
Strength: 1280 UNIT / VIAL
Monograph: PROTEIN S